Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2013 / N 2

Современные подходы к диагностике и коррекции эндотелиальной дисфункции у пациентов с артериальной гипертонией (рекомендуемая литература)
Т.К. Чернявская

Бахтияров Р.З, Забиров М.Р., Гипертоническая болезнь и эндотелиальная дисфункция, Вестник ОГУ, 2004. ? 4. С 114–118. Бувальцев В.И., Дисфункция эндотелия как новая концепция профилактики и лечения сердечно-сосудистых заболеваний, Международный Медицинский журнал, 2001, ?3. С. 202–209. Маколкин В.И., Подзолков В.И., Ренскова Т.В. Оценка влияния периндоприла на величину артериального давления, ремоделирование сосудов и микроциркуляцию при гиперто нической болезни. Кардиология. 2001; 6: 13–7 Малов К.В., Эндотелиальная дисфункция и сердечно-сосудистые заболевания: возможности терапии ингибиторами ангиотензин-превращающего фермента, Терапия, 2003, ?4; http://razom.znaimo.com.ua/docs/21470/index-54189-1.html Allison A. 70. Roberts CK, Vaziri ND, Wang XQ, Barnard RJ Enhanced NO inactivation and hypertension induced by a highfat, refinedcarbohydrate diet. Hypertension 2000 Sep; 36(3) 4239 Anderson T.J. Assessment and treatment of endothelial dysfunction in humans. // Journal of the American College of Cardiology 1999; 34: 631-8. Anderson T.J., et al. Systemic nature of endothelial dysfunction in atherosclerosis. // The American Journal of Cardiology 1995; 75: 71B-74B. Arnal JF., Michel JB., Harrison DG. Nitric oxide in the pathogenesis of hypertension. Curr Opin Nephrol Hypertens 1995 Mar;4(2):1828 Baylis C., Vallance P. Nitric oxide and blood pressure: effects of nitric oxide deficiency. Curr Opin Nephrol Hypertens 1996 Jan;5(1):808 Booz G.W., Baker K.M. Role of type 1 and type 2 angiotensin receptors in angiotensin IIinduced cardiomyocyte hypertrophy. Hypertension. 1996; 28: 635640. Bots ML, Remme WJ, Luscher TF et al. ACE Inhibition and Endothelial Function: Main Findings of PERFECT, a Sub-Study of the EUROPA Trial Cardiovasc Drugs Ther 2007; 21 (4): 269–79 Boulanger C., Vanhoutte P.M. [The role of the endothelium in the regulation of vasomotor activity]. Arch Mal Coeur Vaiss 1991 Jan; 84 Spec No 1:3544 Boulanger CM. Endothelial NO synthase C R Seances Soc Biol Fil 1995;189(6):106979 Brown., Frank B Hu Dietary modulation of endothelial function:implications for cardiovascular disease. American Journal of Clinical Nutrition, 2001; 73 ?4 673686. Busse R. Luckhoff A., Bassenge E. Endotheliumderived relaxing factor inhibits platelet activation. NaunynSchmiedebergs Arch Pharmacol 1987; 336: 562566 Busse R., et al. Endothelial dysfunction in atherosclerosis. // Journal of Vascular Research 1996; 33: 181-194. Carl J.Pepine, David S. Celermajer, Helmut Drexler Vascular health as a therapeutic tagert in cardiovascular disease. University of Florida, 1998 Ceconi C, Francolini G, Bastianon D et al. Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis in vivo and in vivo studies. Cardovasc Drugs Ther 2007; 21: 423–9 Celermajer D.S., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. // The Lancet 1992; 340:1111-5. Celermajer D.S. Endothelial dysfunction: Does it matter? Is it reversible? // Journal of the American College of Cardiology 30; 2: 325-332. Cleland SJ., Petrie JR., Ueda S., Elliott HL., Connell JM. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease Clin Exp Pharmacol Physiol 1998 MarApr;25(34):175-84 Clozel M. Mechanism of action of angiotensin converting enzyme inhibitors on endothelial function in hypertension. Hypertension 1991; 18:3742. Cooke J., Tsao P. Is nitric oxide an endogenous antiatherogenic molecule? Arterioscler Thromb. 1994; 14: 653-655 Dzau VJ., Gibbon GN. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension. 1991; 18 (suppl III): III 115-III121 Ignarro LJ. Endotheliumderived nitric oxide: actions and properties, FASEB J 1989 Jan;3(1):316 Gardiner SM., Compton AM., Bennet T., Palmer RMJ., Moncada S. Control of regional blood flow by endotheliumderived nitric oxide. Hypertension 1990; 15: 486-492 Grag UC., Hassid A. Nitric oxide generating vasodilators and 8bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989; 83:1774-1777 Faraci FM., Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 1998 Jan;78(1):5397 Ford W.R., Clanachen A.S., Jugdutt B.I. Opposite effect of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemiareperfusion in isolated working rat heats. Circulation. 1996; 94: 3087-3089 Fukuhara M., Diz DI., Ferrario CM., Brosnihan KB. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)induced vasoconstriction in canine coronary arteries and human platelet aggregation. J Pharmacol Exp Ther 2000 Jan;292(1):238-46 Furchgott RF., Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376 JeanBaptiste Michel NO (Nitric oxide) and Cardiovascular Homeostasis 1999 Menarini International Industrie Farmaceutiche Riunite s.r.l. Paris Haller H. Endothelial function. General considerations. Drugs 1997;53 Suppl 1:110 Kader KN., Akella R., Ziats NP., Lakey LA., Harasaki H., Ranieri JP., Bellamkonda RV. eNOSoverexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro. Tissue Eng 2000 Jun; 6(3):241-51 Kibbe M., Billiar T., Tzeng E. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 1999 Aug 15;43(3): 6507 Kuboki K., Jiang ZY., Takahara N., Ha SW., Igarashi M., Yamauchi T., Feener EP., Herbert TP., Rhodes CJ., King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000 Feb 15;101(6):676-81 Kingwell BA. Nitric oxidemediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J 2000 Sep;14(12):1685-96 Lin PJ., Chang CH. Endothelium dysfunction in cardiovascular diseases. Chang Keng I Hsueh 1994 Sep;17(3):198-210 Linder L., Kiowski W., Buhler FR., Luscher TF. Indirect evidence for release of endotheliumderived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767 Lippincott William et al. Insulin, nitric oxide and sympathetic nervous system: at the crossroad of metabolic and cardiovascular regulation Hypertension 1999;17:1517-1525 Lorenzo Ghiadoni; Agostino Virdis; Armando Magagna; Stefano Taddei; Antonio Salvetti Effect of the Angiotensin II Type 1 Receptor Blocker Candesartan on Endothelial Function in Patients With Essential Hypertension Hypertension. 2000; 35:501 Lyons D., Webster J., Benjamin N. The effect of antihypertensive therapy on responsiveness to local intrarterial NGmonomethylLarginine in patients with essential hypertension. J Hypertens. 1994;12:1047-1053 Luscher T.F. Endothelial control of vascular tone and growth. Clin Exp Hypertens [A] 1990;12(5):897-902 Luscher T.F. Endotheliumderived vasoactive factors and regulation of vascular tone in human blood vessels. Lung 1990;168 Suppl:27-34 Luscher T.F., Noll.G. The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis 1995 Dec;118 Suppl:S81-90 Luscher T.F., Barton M. Biology of the endothelium. Clin Cardiol 1997 Nov;20(11 Suppl 2):II310 Luscher T.F., Wenzel RR, Noll G. Local regulation of the coronary circulation in health and disease: role of nitric oxide and endothelin Eur Heart J 1995 May;16 Suppl C:518 Luscher T.F., Vanhoutte P.M. In: The endothelium: modulator of cardiovascular function. Boca Raton, FL: CRC Press; 1990 Luscher T.F. Endotheliumderived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system. Eur Heart J 1991 Nov;12 Suppl E:211 Mancini G.B.J., Henry G.C., Macaya C. et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) study // Circulation. – 1996. – Vol. 94. – P. 258-265. Moncada S., Higgs A., Furchott RE. XIV Inernational union of pharmacology nomenclature in nitric oxide research. Phatmacol Rev 1997;49:137-142 Moncada S., Palmer R.M., Higgs E.A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 1988 Oct;12(4):365-72 Nagao T., Vanhoutte P.M. Endotheliumderived hyperpolarizing factor and endotheliumdependent relaxations. Am J Respir Cell Mol Biol 1993 Jan;8(1):16 Naruse M., Tanabe A., Takagi S., Tago K., Takano K. Insulin resistance and vascular function. Nippon Rinsho 2000 Feb;58(2):34-47 Noll G., Tschudi M., Nava E., Luscher TF. Endothelium and high blood pressure. Int J Microcirc Clin Exp 1997 Oct;17(5):27-39 Palmer RMJ, Ashton DS., Moncada S. Vascular endothelial cells synthesize nitric oxide from Larginine. Nature. 1988;333:664-666 Palmer RMJ., Ferrige AG., Moncada S. Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature. 1987;327:524-526 Panza JA. Endothelial dysfunction in essential hypertension. Clin Cardiol 1997 Nov;20(11 Suppl 2):II2633 Panza JA., Casino PR., Kilcoyne CM., Quyyumi AA. Role of endotheliumderived nitric oxide in the abnormal endotheliumdependent vascular relaxation of patients with essential hypertension Circulation. 1993; 87: 1468-1474 Panza JA., Quyyumi AA., Brush JE., Epstein SE. Abnormal endotheliumdependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27 Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998 Jul 6;105(1A):32-39 Raitakari O.T., et al. Testing for endothelial dysfunction. // Annals of Medicine 2000; 32: 293- 304. Rapoport RM., Draznin MB., Murad F. Endotheliumdependent relaxation in rat aorta may be mediated through cyclic GMFdependent protein phosphorylation. Nature 1983; 306: 174-176 Rizzoni D., Porteri E., Castellano M., Bettoni G., Muiesan ML., Tiberio G., Giulini SM., Rossi GP., Bernini G., AgabitiRosei E. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension. 1998;31(pt 2):335-341. Rongen G.A, Smits P, Thien T. Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications. Neth J Med 1994 Jan;44(1):26-35 Roland Govers and Ton J. Rabelink Cellular regulation of endothelial nitric oxide synthase Am. J. Physiol. February 2001. 280: Vol. 280, Issue 2, F193-F206 Roxana Campisi, Johannes Czernin, Heiko Schoder, James W. Sayre, Fernando D. Marengo, Michael E. Phelps, Heinrich R. Schelbert Effects of Longterm Smoking on Myocardial Blood Flow, Coronary Vasomotion, and Vasodilator Capacity Circulation 1998;98:119-125 Schiffrin E.L. The endothelium of resistance arteries: physiology and role in hypertension.Prostaglandins Leukot Essent Fatty Acids 1996 Jan;54(1):17-25 Simon A., Castro A., Kaski JC. Assessment of endothelial dysfunction and its clinical usefulness.Rev Esp Cardiol 2001 Feb;54(2):2117 Siragy HM, de Gasparo M, Carey RM Angiotensin type 2 receptor mediates valsartaninduced hypotension in conscious rats. Hypertension 2000 May; 35(5): 107-47. Shimokawa H. Endothelial dysfunction in hypertension. J Atheroscler Thromb 1998;4(3):118-27 Shoemaker JK., Bonen A. Vascular actions of insulin in health and disease. Can J Appl Physiol 1995 Jun;20(2):127-54 Stoll M., Steckelings M., Paul M., Bottari S.R., Metzger R., Unger T. The angiotensin AT2receptor mediates inhibition of cell proliferation in coronary endothelial cells. J.Clin. Invest.1995; 95: 651-657. Taddei S., Salvetti A. Pathogenetic factors in hypertension. Endothelial factors. Clin Exp Hypertens 1996 AprMay;18(34):323-35 Taddei S., Virdis A., Ghiadoni L., Salvetti A. The role of endothelium in human hypertension Curr Opin Nephrol Hypertens 1998 Mar;7(2):20-39 The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients // New Engl. J. Med. – 2000. – Vol. 342. – P. 145-153. Tiritilli A Nitric oxide (NO), vascular protection factor. Biology, physiological role and biochemistry of NO. Presse Med 1998 Jun 13;27(21):106-14 Tohru Fukai, Martin R. Siegfried, Masuko UshioFukai, Yian Cheng, Georg Kojda and David G. Harrison Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training J Clin Invest, June 2000, Volume 105, Number 11, 1631-1639 Tschudi MR., Luscher TF. Nitric oxide: the endogenous nitrate in the cardiovascular system Herz 1996 Jun;21 Suppl 1:50-60 Van Zwieten PA. Endothelial dysfunction in hypertension. A critical evaluation. Blood Press Suppl 1997;2:67-70 Vanhoutte PM. Endothelial dysfunction in hypertension J Hypertens Suppl 1996 Dec;14(5):S83-93 Vanhoutte PM., Boulanger CM. Endotheliumdependent responses in hypertension. Hypertens Res 1995 Jun;18(2):87-98
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]